Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19-Reference-Cited by-同舟云学术

Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19

Published:2021-04-09 Issue:4 Volume:4 Page:e215298
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Preston Leigh Ellyn¹,Chevinsky Jennifer R.¹²,Kompaniyets Lyudmyla¹,Lavery Amy M.¹,Kimball Anne¹²,Boehmer Tegan K.¹³,Goodman Alyson B.¹³

Affiliation:

1. COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia

2. Epidemic Intelligence Service, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia

3. Commissioned Corps, US Public Health Service, Rockville, Maryland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2778347/preston_2021_ld_210048_1617280541.87195.pdf

Reference6 articles.

1. Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19—COVID-NET, 14 states, March 1-July 25, 2020.;Kim;MMWR Morb Mortal Wkly Rep,2020

2. Coronavirus disease 2019 case surveillance—United States, January 22-May 30, 2020.;Stokes;MMWR Morb Mortal Wkly Rep,2020

3. Comparison of EHR-based diagnosis documentation locations to a gold standard for risk stratification in patients with multiple chronic conditions.;Martin;Appl Clin Inform,2017

4. American Academy of Pediatrics and the Children’s Hospital Association. Children and COVID-19: state data report: a joint report from the American Academy of Pediatrics and the Children’s Hospital Association. Version 12/24/20. Accessed December 31, 2020. https://downloads.aap.org/AAP/PDF/AAP%20and%20CHA%20-%20Children%20and%20COVID-19%20State%20Data%20Report%2012.24.20%20FINAL.pdf

5. Premier Applied Science. Premier healthcare database (COVID-19): data that informs and performs. April 2020. Accessed December 30, 2020. http://offers.premierinc.com/rs/381-NBB-525/images/PHD_COVID-19_White_Paper.pdf

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine;Vaccine;2024-09

2. Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6–17 Years: An Immunobridging Trial;Vaccines;2024-06-19

3. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis;Journal of the Pediatric Infectious Diseases Society;2024-05-23

4. Retrospective Analysis of Clinical Characteristics and Disease Outcomes in Children and Adolescents Hospitalized Due to COVID-19 Infection in Tunisia;Viruses;2024-05-14

5. Multisystemic inflammatory syndrome in children and the BNT162b2 vaccine: a nationwide cohort study;European Journal of Pediatrics;2024-05-09